Literature DB >> 8987952

The management of placenta percreta: conservative and operative strategies.

J M O'Brien1, J R Barton, E S Donaldson.   

Abstract

OBJECTIVE: Our purpose was to assess preferences for the management of placenta percreta and identify aspects of care related to an improved outcome. STUDY
DESIGN: Both an analysis of a questionnaire issued to members of the Society of Perinatal Obstetricians and a retrospective study at our institution were used to obtain case histories of women with placenta percreta during a recent 3-year period.
RESULTS: Fifty-five of the 109 cases (50%) reported by members of the Society of Perinatal Obstetricians were suspected ante partum. Complications associated with this disorder included uterine rupture (3 cases), transfusion of > 10 units (44 cases, 40%), ureteral ligation or fistula formation (5 cases each, 5%), infection (31 cases, 28%), perinatal death (10 cases, 9%), and maternal death (8 cases, 7%). Management options included surgical removal of the uterus and involved tissues (101 cases, 93%) and conservative treatment with the placenta left in situ after delivery (8 cases, 7%). More members of the Society of Perinatal Obstetricians responding to our survey opted for conservative management if adjacent tissues were involved (69% with extension into the bladder or gastrointestinal tract) compared with 31% when the percreta was confined to the uterus, p < 0.001. Conservative therapy was also associated with less blood loss in reported cases (median units red blood cells transfused, 0 vs 7, p = 0.003). Two of the three cases of placenta percreta at our institution were identified ante partum. The third case represents the first reported with antepartum identification of percreta followed by deliberate conservative treatment.
CONCLUSIONS: With greater involvement of surrounding tissues, conservative treatment was preferred in hemodynamically stable patients. If surgical excision of the placenta is attempted or necessary, physicians experienced in pelvic dissection must be involved because of the frequency of maternal morbidity and mortality.

Entities:  

Mesh:

Year:  1996        PMID: 8987952     DOI: 10.1016/s0002-9378(96)70117-5

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  46 in total

Review 1.  Autologous blood in obstetrics: where are we going now?

Authors:  Giancarlo Maria Liumbruno; Chiara Liumbruno; Daniela Rafanelli
Journal:  Blood Transfus       Date:  2011-10-25       Impact factor: 3.443

2.  Maternal and fetal death at 22 weeks following uterine rupture at the site of the placenta percreta in a C-section scar.

Authors:  Lucy M Bradley; Jamil A K Addas; Jayantha C Herath
Journal:  Forensic Sci Med Pathol       Date:  2019-06-21       Impact factor: 2.007

3.  Magnetic resonance imaging in the evaluation of placental adhesive disorders: correlation with color Doppler ultrasound.

Authors:  Gabriele Masselli; Roberto Brunelli; Emanuele Casciani; Elisabetta Polettini; Maria Grazia Piccioni; Maurizio Anceschi; Gianfranco Gualdi
Journal:  Eur Radiol       Date:  2008-02-01       Impact factor: 5.315

4.  Surgical management of 58 patients with placenta praevia percreta.

Authors:  Aysun Camuzcuoglu; Mehmet Vural; Nese Gul Hilali; Adnan Incebiyik; Hasan Husnu Yuce; Ahmet Kucuk; Hakan Camuzcuoglu
Journal:  Wien Klin Wochenschr       Date:  2016-02-25       Impact factor: 1.704

5.  Morbidly adherent placenta: a critical review.

Authors:  Richa Aggarwal; Amita Suneja; Neelam Bala Vaid; Ponam Yadav; Abha Sharma; Kiran Mishra
Journal:  J Obstet Gynaecol India       Date:  2012-04-20

6.  Expectant and medical management of placenta increta in a primiparous woman presenting with postpartum haemorrhage: The role of Imaging.

Authors:  Papa Dasari; Bhuvaneswari Venkatesan; Chitra Thyagarajan; Sathyalakshmy Balan
Journal:  J Radiol Case Rep       Date:  2010-05-01

7.  Conservative management of placenta previa percreta by leaving placental tissue in situ with arterial ligation and adjuvant methotrexate therapy.

Authors:  Teksin Cırpan; Cem Yaşar Sanhal; Sait Yücebilgin; Serdar Ozşener
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-06-01

8.  Second trimester placenta percreta presenting as acute abdomen.

Authors:  Lauren Dew; Steven Harris; Nicole Yost; Kevin Magee; Gregory dePrisco
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-01

9.  Prophylactic occlusion balloon placement in internal iliac arteries for the prevention of postpartum haemorrhage due to morbidly adherent placenta: short term outcomes.

Authors:  Salvatore Alessio Angileri; Leto Mailli; Claudio Raspanti; Anna Maria Ierardi; Gianpaolo Carrafiello; Anna-Maria Belli
Journal:  Radiol Med       Date:  2017-05-27       Impact factor: 3.469

10.  Preservation of fertility following abnormally adherent placenta treated conservatively: a case report.

Authors:  Rajiv Mahendru; Bal K Taneja; Savita Malik
Journal:  Cases J       Date:  2009-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.